Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled Trial of Erythropoietin Alfa Versus Placebo in Mechanically Ventilated Critically Ill Patients Following Traumatic Injury

NCT04588311 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.

NCT NCT04588311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04588311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled Trial of Erythropoietin Alfa Versus Placebo in Mechanically Ventilated Critically Ill Patients Following Traumatic Injury
Lead sponsor
Australian and New Zealand Intensive Care Research Centre
Phase
Phase 3
Overall status
Recruiting
Start date
November 9, 2020
Completion date
August 31, 2027
Enrollment
2,500 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

blunt injury, major trauma, multiple trauma, penetrating injury, trauma, traumatic brain injury, traumatic injury, wounds and injuries